TrialNeuro-oncology2024

A combinatory vaccine with IMA950 plus varlilumab promotes effector memory T-cell differentiation in the peripheral blood of patients with low-grade gliomas.

Atsuro Saijo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.